title: [Metabolic disorder after androgen deprivation therapy in patients with prostate cancer].
abstract: The prevalence of prostate cancer, a common malignancy of urinary system in elderly males, has increased rapidly in China in recent years. Currently most prostate cancer patients are treated with androgen deprivation therapy (ADT). However, ADT-induced metabolic disorders such as metabolic syndrome has remarkably impaired the quality of life and decreased the survival rate.
authors: Department of Urology, Peking University Peoples Hospital, Beijing, China.
authors: Jia-qi
authors: JQ
authors: Yuan
authors: Xiao-wei
authors: XW
authors: Zhang
authors: Tao
authors: T
authors: Xu
authors: Xiao-feng
authors: XF
authors: Wang
mesh_terms: D000726:Androgen Antagonists / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008659:Metabolic Diseases / Q000139:chemically induced*; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000378:metabolism
chemical_list: D000726:Androgen Antagonists